Couturier J et al. |
Steroid-induced mania in an adolescent: risk factors and management. |
2001 |
Can J Clin Pharmacol |
pmid:11493940
|
Cicconi V et al. |
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. |
2001 |
Am. J. Med. |
pmid:11501549
|
Kanamaru T et al. |
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11502514
|
Chu HW et al. |
Evaluation of blood vessels and edema in the airways of asthma patients: regulation with clarithromycin treatment. |
2001 |
Chest |
pmid:11502638
|
Holmberg SD and Moorman AC |
Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis. |
2001 |
AIDS |
pmid:11504998
|
Avcu N et al. |
The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia. |
2001 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:11505263
|
González C et al. |
[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. |
2001 |
Rev Med Chil |
pmid:11510204
|
Andersson T et al. |
Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. |
2001 |
Clin Pharmacokinet |
pmid:11510629
|
Azuma T et al. |
Gastric leptin and Helicobacter pylori infection. |
2001 |
Gut |
pmid:11511551
|
Martinot JB et al. |
A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis. |
2001 Jan-Feb |
Adv Ther |
pmid:11512528
|
Froehlich F et al. |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. |
2001 |
Am. J. Gastroenterol. |
pmid:11513170
|
Maconi G et al. |
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile? |
2000 |
Dig Liver Dis |
pmid:11515622
|
Kim YG et al. |
Bioequivalence of clarithromycin tablet formulations assessed in Korean males. |
2001 |
Int J Clin Pharmacol Ther |
pmid:11515711
|
Sazhin VP and Fedorov AV |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. |
2001 |
Khirurgiia (Mosk) |
pmid:11517693
|
Maev IV et al. |
[Experience in the use of losek (omeprazole) in gastroenterology]. |
2001 |
Ter. Arkh. |
pmid:11523419
|
Douthwaite S |
Structure-activity relationships of ketolides vs. macrolides. |
2001 |
Clin. Microbiol. Infect. |
pmid:11523556
|
Wongkusoltham P et al. |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease. |
2001 |
J Med Assoc Thai |
pmid:11529378
|
Schlegel L et al. |
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999. |
2001 |
Clin. Microbiol. Infect. |
pmid:11531981
|
Miyashita N et al. |
In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae. |
2001 |
J. Antimicrob. Chemother. |
pmid:11533006
|
Weiss K et al. |
In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae. |
2001 |
J. Antimicrob. Chemother. |
pmid:11533007
|
Miyazaki S et al. |
Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. |
2001 |
J. Antimicrob. Chemother. |
pmid:11533011
|
Bujanda L et al. |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days]. |
2001 |
An Med Interna |
pmid:11534420
|
Naqvi B et al. |
Efficacy of clarithromycin in preventing viridans streptococcal bacteremia following autologous stem cell transplantation. |
2001 |
Infection |
pmid:11545480
|
Beales IL |
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. |
2001 |
BMC Gastroenterol |
pmid:11545677
|
Bharani A and Kumar H |
Drug points: Diabetes inspidus induced by ofloxacin. |
2001 |
BMJ |
pmid:11546701
|
Fichtenbaum CJ et al. |
Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman. |
2001 |
AIDS |
pmid:11546956
|
Yamanaka Y et al. |
Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11549274
|
Acar JF |
A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. |
2001 |
Chemotherapy |
pmid:11549785
|
Gisbert JP and Pajares JM |
Helicobacter pylori therapy: first-line options and rescue regimen. |
2001 |
Dig Dis |
pmid:11549823
|
Magaret N et al. |
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. |
2001 |
Dig Dis |
pmid:11549829
|
Di Vita G et al. |
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. |
2001 |
Dig Dis |
pmid:11549830
|
Müller H et al. |
Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication. |
2001 |
Digestion |
pmid:11549834
|
Bühling A et al. |
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552917
|
Hokari K et al. |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552922
|
Kamberoglou D et al. |
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552924
|
Hayashi T et al. |
Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. |
2001 |
Infect. Immun. |
pmid:11553555
|
Kroegel C et al. |
Chlamydia pneumoniae, clarithromycin, and severe asthma. |
2001 |
Chest |
pmid:11555549
|
Nishimoto A et al. |
Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex. |
2001 |
Chem. Pharm. Bull. |
pmid:11558597
|
Scott LJ et al. |
Cefuroxime axetil: an updated review of its use in the management of bacterial infections. |
2001 |
Drugs |
pmid:11558834
|
Yang JC et al. |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy. |
1999 |
J Microbiol Immunol Infect |
pmid:11561564
|
Kume K et al. |
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. |
2001 |
Am. J. Gastroenterol. |
pmid:11569719
|
Chey WD and Fendrick AM |
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. |
2001 |
Arch. Intern. Med. |
pmid:11570943
|
Amsden GW |
Advanced-generation macrolides: tissue-directed antibiotics. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11574189
|
Rubinstein E |
Comparative safety of the different macrolides. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11574199
|
Fukushima K et al. |
[A case of post-tuberculosis chronic empyema with effective low-dose, long-term clarithromycin administration]. |
2001 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11579526
|
Ikeue T et al. |
[Pneumonia caused by Nocardia nova]. |
2001 |
Nihon Kokyuki Gakkai Zasshi |
pmid:11579529
|
Kerr JR and Preston NW |
Current pharmacotherapy of pertussis. |
2001 |
Expert Opin Pharmacother |
pmid:11584995
|
Tse KC et al. |
Delusion of worm infestation associated with clarithromycin in a patient on peritoneal dialysis. |
2001 Jul-Aug |
Perit Dial Int |
pmid:11587409
|
Sillakivi T et al. |
An attempt at Helicobacter pylori eradication with intravenous clarithromycin in perforated peptic ulcer patients. |
2001 |
Scand. J. Gastroenterol. |
pmid:11589389
|
Okazaki N et al. |
Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. |
2001 |
Microbiol. Immunol. |
pmid:11592636
|
Yakoob J et al. |
Antibiotic susceptibility of Helicobacter pylori in the Chinese population. |
2001 |
J. Gastroenterol. Hepatol. |
pmid:11595061
|
Keto Y et al. |
Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication. |
2001 Jan-Dec |
J. Physiol. Paris |
pmid:11595471
|
Buzás GM et al. |
Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999). |
|
J. Physiol. Paris |
pmid:11595472
|
Chahine C et al. |
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori. |
2001 |
Am J Health Syst Pharm |
pmid:11596697
|
Agro K et al. |
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication. |
2001 |
Pharmacoeconomics |
pmid:11596835
|
Hyde TB et al. |
Macrolide resistance among invasive Streptococcus pneumoniae isolates. |
2001 |
JAMA |
pmid:11597287
|
Ling KL et al. |
Efficacy of a nitroimidazole containing tripletherapy regime in Singapore. |
2001 |
Singapore Med J |
pmid:11599627
|
Lounis N et al. |
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600387
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600400
|
Bigard MA |
[Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies]. |
2001 |
Presse Med |
pmid:11603094
|
Tankovic J et al. |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. |
2001 |
Pathol. Biol. |
pmid:11642014
|
Timm S et al. |
First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori. |
2001 |
Gastroenterology |
pmid:11665693
|
Saruç M et al. |
The effect of CagA status on response to Helicobacter pylori eradication therapy in Western Turkey. |
2001 |
Braz. J. Med. Biol. Res. |
pmid:11668353
|
Kumar D et al. |
Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study. |
2001 Sep-Oct |
Indian J Gastroenterol |
pmid:11676331
|
Moayyedi P et al. |
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. |
2001 |
Gastroenterology |
pmid:11677204
|
Schlünzen F et al. |
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. |
2001 |
Nature |
pmid:11677599
|
Gisbert JP et al. |
Are twelve days of omeprazole, amoxicillin and clarithromycin better than six days for treating H. pylori infection in peptic ulcer and in non-ulcer dyspepsia? |
2001 Sep-Oct |
Hepatogastroenterology |
pmid:11677970
|
Xu H and Rashkow A |
Clarithromycin-induced digoxin toxicity: a case report and a review of the literature. |
2001 |
Conn Med |
pmid:11678058
|
Kanj SS et al. |
Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literature. |
2001 |
Clin. Microbiol. Infect. |
pmid:11678937
|
Lascols C et al. |
Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin. |
2001 |
J. Antimicrob. Chemother. |
pmid:11679568
|
Guyot A and Barrett SP |
What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea? |
2001 |
J. Antimicrob. Chemother. |
pmid:11679574
|
Keto Y et al. |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. |
2001 |
Nippon Yakurigaku Zasshi |
pmid:11680169
|
Rüssmann H et al. |
Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. |
2001 |
J. Clin. Microbiol. |
pmid:11682543
|
Ikeda S et al. |
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11683692
|
Laurent J et al. |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11683693
|
Asaka M et al. |
Guidelines in the management of Helicobacter pylori infection in Japan. |
2001 |
Helicobacter |
pmid:11683920
|
Ozen H et al. |
Helicobacter pylori infection and recurrent abdominal pain in Turkish children. |
2001 |
Helicobacter |
pmid:11683926
|
McNulty CA et al. |
A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. |
2001 |
Helicobacter |
pmid:11683929
|
Asaka M et al. |
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. |
2001 |
Helicobacter |
pmid:11683930
|
McCarty JM and Pierce PF |
Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis. |
2001 |
Ann. Allergy Asthma Immunol. |
pmid:11686426
|
Dubois J and St-Pierre C |
In vitro susceptibility study of BMS-284756 against Legionella species. |
2001 Sep-Oct |
Diagn. Microbiol. Infect. Dis. |
pmid:11687318
|
Vichev E et al. |
[Gastroduodenitis and ulcers--statistical study for 1998]. |
2000 |
Vutr Boles |
pmid:11688321
|
Stratchounski LS et al. |
Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11691567
|
Zheng X et al. |
Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11691571
|
Dzierzanowska-Fangrat K et al. |
Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. |
2001 |
Int. J. Antimicrob. Agents |
pmid:11691574
|
Dandekar SS and Laidlaw DA |
Suprachoroidal haemorrhage after addition of clarithromycin to warfarin. |
2001 |
J R Soc Med |
pmid:11691898
|
Gisbert JP et al. |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. |
2001 |
Eur J Gastroenterol Hepatol |
pmid:11692055
|
Mayr-Kanhäuser S et al. |
Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. |
2001 |
Eur J Gastroenterol Hepatol |
pmid:11692067
|
Horsburgh CR et al. |
Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000. |
2001 |
Clin. Infect. Dis. |
pmid:11692307
|
Heurtin C et al. |
[Comparative study of the bacteriostatic and bactericidal activity of levofloxacin against Pasteurella strains isolated from man]. |
2001 |
Pathol. Biol. |
pmid:11692747
|
Matheson AJ and Jarvis B |
Lansoprazole: an update of its place in the management of acid-related disorders. |
2001 |
Drugs |
pmid:11693467
|
Chai D et al. |
[Effect of macrolides on biofilm of mucoid Pseudomonas aeruginosa]. |
2001 |
Zhonghua Yi Xue Za Zhi |
pmid:11702671
|
Ena P et al. |
Rapid identification of cutaneous infections by nontubercular mycobacteria by polymerase chain reaction-restriction analysis length polymorphism of the hsp65 gene. |
2001 |
Int. J. Dermatol. |
pmid:11703519
|
Carabias ML et al. |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study]. |
2001 |
Rev Esp Quimioter |
pmid:11704772
|
Okano A et al. |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. |
2001 |
Bone Marrow Transplant. |
pmid:11704796
|
Capitano B et al. |
Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children. |
2001 |
Paediatr Drugs |
pmid:11706922
|
Ramón Maestre J et al. |
[Bacteremia caused by Campylobacter jejuni in a 22 year old male with autoimmune haemolytic anaemia]. |
2001 |
Enferm. Infecc. Microbiol. Clin. |
pmid:11709134
|
Komori T et al. |
Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes. |
2001 |
Biochem. Pharmacol. |
pmid:11709199
|
Endo H et al. |
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11709323
|